These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34560383)

  • 21. Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.
    Guerriero MK; Redman MW; Baker KK; Martins RG; Eaton K; Chow LQ; Santana-Davila R; Baik C; Goulart BH; Lee S; Rodriguez CP
    Cancer; 2018 Jul; 124(13):2841-2849. PubMed ID: 29669181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129.
    Xiao C; Zhang Q; Nguyen-Tân PF; List M; Weber RS; Ang KK; Rosenthal D; Filion EJ; Kim H; Silverman C; Raben A; Galloway T; Fortin A; Gore E; Winquist E; Jones CU; Robinson W; Raben D; Le QT; Bruner D
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):667-677. PubMed ID: 27727063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined Nimotuzumab with Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.
    Thai Hoa NT; Quang Huy H
    Cureus; 2020 May; 12(5):e8105. PubMed ID: 32426197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation.
    Fang FM; Tsai WL; Chien CY; Chiu HC; Wang CJ; Chen HC; Hsiung CY
    Oncology; 2005; 68(4-6):405-13. PubMed ID: 16020970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial.
    Tao Y; Auperin A; Blanchard P; Alfonsi M; Sun XS; Rives M; Pointreau Y; Castelli J; Graff P; Wong Hee Kam S; Thariat J; Veresezan O; Heymann S; Renard-Oldrini S; Lafond C; Cornely A; Casiraghi O; Boisselier P; Lapeyre M; Biau J; Bourhis J
    Radiother Oncol; 2020 Sep; 150():18-25. PubMed ID: 32417348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase 2 randomized study to compare short course palliative radiotherapy with short course concurrent palliative chemotherapy plus radiotherapy in advanced and unresectable head and neck cancer.
    Kumar A; Sharma A; Mohanti BK; Thakar A; Shukla NK; Thulkar SP; Sikka K; Bhasker S; Singh CA; Vishnubhatla S
    Radiother Oncol; 2015 Oct; 117(1):145-51. PubMed ID: 26303014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin.
    van der Vorst MJDL; Neefjes ECW; Toffoli EC; Oosterling-Jansen JEW; Vergeer MR; Leemans CR; Kooistra MP; Voortman J; Verheul HMW
    BMC Cancer; 2019 Nov; 19(1):1066. PubMed ID: 31703649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer.
    Kataoka T; Kiyota N; Shimada T; Funakoshi Y; Chayahara N; Toyoda M; Fujiwara Y; Nibu K; Komori T; Sasaki R; Mukohara T; Minami H
    Auris Nasus Larynx; 2016 Dec; 43(6):677-84. PubMed ID: 26992271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial.
    de Castro Junior G; Segalla JG; de Azevedo SJ; Andrade CJ; Grabarz D; de Araújo Lima França B; Del Giglio A; Lazaretti NS; Álvares MN; Pedrini JL; Kussumoto C; de Matos Neto JN; Forones NM; Fernandes Júnior HJ; Borges G; Girotto G; da Silva IDCG; Maluf-Filho F; Skare NG
    Eur J Cancer; 2018 Jan; 88():21-30. PubMed ID: 29179134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of life.
    Wang K; Amdur RJ; Mendenhall WM; Green R; Aumer S; Hackman TG; Zanation AM; Zevallos JP; Patel SN; Weissler MC; Chera BS
    Oral Oncol; 2016 Jul; 58():21-6. PubMed ID: 27311398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase IIb trial comparing two concurrent cisplatin schedules in locally advanced head and neck cancer.
    Nair LM; Kumar RR; Thomachan KC; Rafi M; George PS; Krishna KMJ; Ramadas K
    South Asian J Cancer; 2017; 6(2):64-68. PubMed ID: 28702409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity.
    Saksø M; Jensen K; Andersen M; Hansen CR; Eriksen JG; Overgaard J
    Radiother Oncol; 2020 Jul; 148():65-72. PubMed ID: 32335364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma: A meta-analysis.
    Tang WH; Sun W; Long GX
    Medicine (Baltimore); 2020 Sep; 99(36):e21785. PubMed ID: 32899005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer.
    Argiris A; Bauman JE; Ohr J; Gooding WE; Heron DE; Duvvuri U; Kubicek GJ; Posluszny DM; Vassilakopoulou M; Kim S; Grandis JR; Johnson JT; Gibson MK; Clump DA; Flaherty JT; Chiosea SI; Branstetter B; Ferris RL
    Ann Oncol; 2016 Aug; 27(8):1594-600. PubMed ID: 27177865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer.
    Bonnetain F; Bouché O; Michel P; Mariette C; Conroy T; Pezet D; Roullet B; Seitz JF; Paillot B; Arveux P; Milan C; Bedenne L
    Ann Oncol; 2006 May; 17(5):827-34. PubMed ID: 16524973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer.
    Ackerstaff AH; Rasch CR; Balm AJ; de Boer JP; Wiggenraad R; Rietveld DH; Gregor RT; Kröger R; Hauptmann M; Vincent A; Hilgers FJ
    Head Neck; 2012 Jul; 34(7):974-80. PubMed ID: 21818820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single-institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancer.
    Hermann GM; Iovoli AJ; Platek AJ; Wang C; Miller A; Attwood K; Bourgeois DJ; Singh AK
    Cancer; 2020 Apr; 126(7):1480-1491. PubMed ID: 31869451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas.
    Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Bourhis J; Deutsch E; Daly-Schveitzer N; Tao Y
    Strahlenther Onkol; 2014 Sep; 190(9):823-31. PubMed ID: 24638267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change in the Quality of Life in Oropharyngeal, Laryngeal and Hypopharyngeal Cancer Patients treated with Volumetric Modulated Arc-Based Concomitant Boost Radiotherapy.
    Kannan P; Mukherji A; Saravanan K; Reddy KS; Vivekanandam S; Shamsudheen C; Santhosh V
    Gulf J Oncolog; 2016 May; 1(21):36-45. PubMed ID: 27250886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.
    Teknos TN; Grecula J; Agrawal A; Old MO; Ozer E; Carrau R; Kang S; Rocco J; Blakaj D; Diavolitsis V; Kumar B; Kumar P; Pan Q; Palettas M; Wei L; Baiocchi R; Savvides P
    Invest New Drugs; 2019 Aug; 37(4):702-710. PubMed ID: 30569244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.